BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6369855)

  • 1. The biochemical pharmacology of carbenoxolone. Its possible mechanisms of action.
    Parke DV
    Acta Gastroenterol Belg; 1983; 46(9-10):437-47. PubMed ID: 6369855
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of carbenoxolone on the gastric mucosal prostaglandin and thromboxane system.
    Peskar BM
    Acta Gastroenterol Belg; 1983; 46(9-10):429-36. PubMed ID: 6324520
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of carbenoxolone on prostaglandin synthesizing and metabolizing enzymes and correlation with gastric mucosal carbenoxolone concentrations.
    Peskar BM
    Scand J Gastroenterol Suppl; 1980; 65():109-14. PubMed ID: 6259713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of carbenoxolone on gastric prostaglandin E release and cytoprotection in the rat.
    Martin A; Gurrieri G; Sturniolo GC; Naccarato R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():409-10. PubMed ID: 6221623
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastric and systemic effects of carbenoxolone and its derivative ISF 2715 in humans.
    Velo GP; Minuz P; Riela A; Brocco G; Degan M; Franco L; Cavallini G
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():361-5. PubMed ID: 2959078
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbenoxolone and deglycyrrhized liquorice have little or no effect on prostanoid synthesis by rat gastric mucosa ex vivo.
    Bennett A; Melhuish PB; Stamford IF
    Br J Pharmacol; 1985 Nov; 86(3):693-5. PubMed ID: 3840708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of leukotriene formation as a mode of action of gastroprotective drugs.
    Lange K; Peskar BA; Peskar BM
    Prog Clin Biol Res; 1987; 242():283-8. PubMed ID: 3671388
    [No Abstract]   [Full Text] [Related]  

  • 8. Mucosal cell turnover in the upper gut of the mouse and its modification by carbenoxolone [proceedings].
    Henman FD; Adams SS
    Br J Pharmacol; 1978 Nov; 64(3):426P-427P. PubMed ID: 719277
    [No Abstract]   [Full Text] [Related]  

  • 9. Cimetidine, carbenoxolone and gastric mucus.
    Guslandi M
    Gut; 1988 Sep; 29(9):1293-4. PubMed ID: 3198010
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of carbenoxolone on gastric release of prostaglandin (PG)E2 in patients with peptic ulcer disease.
    Rask-Madsen J; Bukhave K; Madsen PE; Bekker C
    Acta Gastroenterol Belg; 1983; 46(9-10):419-28. PubMed ID: 6585111
    [No Abstract]   [Full Text] [Related]  

  • 11. Carbenoxolone interactions in man--preliminary report.
    Thornton PC; Papouchado M; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():35-9. PubMed ID: 6937939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of mineralocorticoid action of carbenoxolone.
    Armanini D; Karbowiak I; Krozowski Z; Funder JW; Adam WR
    Endocrinology; 1982 Nov; 111(5):1683-6. PubMed ID: 6290195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of carbenoxolone on the synthesis of glycoproteins and DNA in rat gastric epithelial cells.
    van Huis GA; Kramer MF
    Gut; 1981 Oct; 22(10):782-7. PubMed ID: 7297910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbenoxolone sodium protects rat gastric mucosa against ethanol-induced necrosis.
    Derelanko MJ; Long JF
    Proc Soc Exp Biol Med; 1981 Mar; 166(3):394-7. PubMed ID: 7208496
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of carbenoxolone on the chronic atrophic gastric mucosa determined by flow cytometry and histoautoradiography.
    Weiss H; Steenbeck L; Gütz HJ; Wolff G
    Digestion; 1981; 21(3):151-5. PubMed ID: 7215718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbenoxolone and incorporation of (3H) glucosamine into gastric mucosa.
    Meek EM; Rhodes J; Mayberry JF
    Curr Med Res Opin; 1978; 5(8):645-7. PubMed ID: 710177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric gel mucus thickness: effect of distention, 16,16-dimethyl prostaglandin e2, and carbenoxolone.
    Bickel M; Kauffman GL
    Gastroenterology; 1981 Apr; 80(4):770-5. PubMed ID: 6162705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of carbenoxolone and prostaglandin E2 on transmucosal potential difference in the rat stomach.
    Watanabe K; Yano S; Yamaguchi T
    Scand J Gastroenterol Suppl; 1989; 162():87-90. PubMed ID: 2595316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric antiulcer and antisecretory effects of carbenoxolone, aldosterone and desoxycorticosterone in rats.
    Dajani EZ; Bianchi RG; Casler JJ; Weet JF
    Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):128-38. PubMed ID: 543742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of carbenoxolone and cimetidine on gastric mucin.
    Guslandi M; Cambielli M; Bierti L; Tittobello A
    Clin Ther; 1980; 3(1):40-2. PubMed ID: 6157471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.